Compass has launched a program allowing listing agents to earn a 10% referral fee for sending buyer leads to other Compass agents. The initiative aims to give agents more control and create new ...

Battery management system (BMS) program expands to support additional battery-electric vehicle (BEV) and plug-in hybrid electric vehicle (PHEV) lines System in production since 2023; expanded ...

Niagara Gospel Mission’s Code Blue program sees an increase in need as frigid temperatures remain. Four things to know about the "Melania" film Schumer calls Trump’s Penn Station renaming claim an ...

Investors were impressed by the company's performance in the final quarter of 2025. It beat analyst expectations on both the top and bottom lines. Bristol Myers' fourth quarter of 2025 saw the veteran ...

Chris Boerner, Bristol Myers Squibb CEO, joins CNBC's "Power Lunch" to discuss the company's quarterly earnings results, the drug pipeline and much more. Got a confidential news tip? We want to hear ...

Bristol Myers Squibb BMY-1.39%decrease; red down pointing triangle reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today reported fourth quarter and full-year 2025 financial results. Visit the company’s Investor ...

Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. The hunt for blockbuster drugs has sent ...

BMS arrived at the American Society of Hematology conference with an hourglass installation. In order to stand out at the clinically-focused event, Real Chemistry created a visually distinct, hopeful ...

Compass, Inc. (NYSE: COMP) stock rose on Friday after the company announced the completion of its all-stock merger with Anywhere Real Estate Inc., finalizing a transaction first announced in September ...

Sometimes it takes a combination of building pressures to spark a landslide of positive change. For pharmaceutical giant Bristol Myers Squibb (BMS), the moment came following its $74 billion ...